Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Theravance Biopharma (TBPH) Inventory Average: 2014-2018

Historic Inventory Average for Theravance Biopharma (TBPH) over the last 5 years, with Sep 2018 value amounting to $17.9 million.

  • Theravance Biopharma's Inventory Average rose 30.84% to $17.9 million in Q3 2018 from the same period last year, while for Sep 2018 it was $17.9 million, marking a year-over-year increase of 30.84%. This contributed to the annual value of $14.5 million for FY2017, which is 30.71% up from last year.
  • As of Q3 2018, Theravance Biopharma's Inventory Average stood at $17.9 million, which was up 2.01% from $17.6 million recorded in Q2 2018.
  • In the past 5 years, Theravance Biopharma's Inventory Average ranged from a high of $17.9 million in Q3 2018 and a low of $9.6 million during Q2 2016.
  • Its 3-year average for Inventory Average is $13.7 million, with a median of $12.7 million in 2017.
  • Its Inventory Average has fluctuated over the past 5 years, first dropped by 22.80% in 2016, then spiked by 38.60% in 2018.
  • Quarterly analysis of 5 years shows Theravance Biopharma's Inventory Average stood at $13.8 million in 2014, then dropped by 19.98% to $11.1 million in 2015, then rose by 11.53% to $12.3 million in 2016, then rose by 29.91% to $16.0 million in 2017, then spiked by 30.84% to $17.9 million in 2018.
  • Its Inventory Average was $17.9 million in Q3 2018, compared to $17.6 million in Q2 2018 and $17.0 million in Q1 2018.